Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEDROXYPROGESTERONE Cause Injection site abscess? 34 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Injection site abscess have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 0.4% of all adverse event reports for MEDROXYPROGESTERONE.

34
Reports of Injection site abscess with MEDROXYPROGESTERONE
0.4%
of all MEDROXYPROGESTERONE reports
0
Deaths
8
Hospitalizations

How Dangerous Is Injection site abscess From MEDROXYPROGESTERONE?

Of the 34 reports, 8 (23.5%) required hospitalization.

Is Injection site abscess Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEDROXYPROGESTERONE. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does MEDROXYPROGESTERONE Cause?

Meningioma (1,364) Drug dose omission by device (510) Device leakage (500) Incorrect dose administered by device (410) Drug ineffective (403) Off label use (390) Syringe issue (354) Needle issue (346) Headache (288) Device occlusion (284)

What Other Drugs Cause Injection site abscess?

NALTREXONE (210) LEUPROLIDE (150) BUPRENORPHINE (110) INTERFERON BETA-1A (73) INTERFERON BETA-1B (58) PALIPERIDONE (54) CABOTEGRAVIR (36) GLATIRAMER (31) OXYMORPHONE (29) RILPIVIRINE (29)

Which MEDROXYPROGESTERONE Alternatives Have Lower Injection site abscess Risk?

MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE MEDROXYPROGESTERONE vs MEFENAMIC ACID MEDROXYPROGESTERONE vs MEFLOQUINE MEDROXYPROGESTERONE vs MEGESTROL MEDROXYPROGESTERONE vs MEGLUMINE

Related Pages

MEDROXYPROGESTERONE Full Profile All Injection site abscess Reports All Drugs Causing Injection site abscess MEDROXYPROGESTERONE Demographics